As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Cryoport, Inc. The largest reported stake is Cadian Capital Management, LP's, at 5.8%. 11 filings are on record since August 5, 2025 (Schedule 13G/A, August 14, 2026).
Sell to companies like Cryoport, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Cadian Capital Management, LP · Sole voting: 0 · Shared voting: 2,920,681 · Sole dispositive: 0 · Shared dispositive: 2,920,681 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: Morgan Stanley · Sole voting: 0 · Shared voting: 2,190,498 · Sole dispositive: 0 · Shared dispositive: 2,246,650 · SCHEDULE 13G/A, 2026-08-13
- · Reporting person: Integrated Core Strategies (US) LLC · Sole voting: 0 · Shared voting: 1,556,718 · Sole dispositive: 0 · Shared dispositive: 1,556,718 · SCHEDULE 13G/A, 2026-07-29
- · Reporting person: The Vanguard Group · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-03-26
- · Holder: Brown Capital Management, LLC · Percent: 2.2% · SCHEDULE 13G/A
Cryoport, Inc. has 11 Schedule 13D or 13G filings on record since 2025-08-05. 1 holder's latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Cadian Capital Management, LP | 5.8% | 2,920,681 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| Alger Associates, Inc. | 4.7% | 2,358,940 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
| 4.5% | 2,246,650 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 | |
| Millennium Management LLC | 3.4% | 1,724,726 | SCHEDULE 13G/A, 2026-07-29 | 2026-06-30 |
| Brown Capital Management, LLC | 2.2% | 1,112,771 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
Holding shares or following this stake? See who's behind Cryoport, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Cryoport, Inc. and the records around it.
Cryoport, Inc. elsewhere on the record
Companies that share a holder
- Alger Associates, Inc. also filed stake reports on 2 other companies: Alger 35 ETF, a series of The Alger ETF Trust (Nov 2026), Forte Biosciences, Inc. (Aug 2026)
- Brown Capital Management, LLC also filed stake reports on 4 other companies: OrthoPediatrics Corp. (Nov 2025)
- Cadian Capital Management, LP also filed stake reports on 7 other companies: Flywire Corp. (Aug 2026), SI-BONE, Inc. (Aug 2026), TACTILE SYSTEMS TECHNOLOGY INC (Aug 2026)
Watch Cryoport, Inc.
Get an email when Cryoport, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Cryoport, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cryoport, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cryoport, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Cadian Capital Management, LP | 0 | 2,920,681 | 0 | 2,920,681 | SCHEDULE 13G/A, 2026-08-14 |
| Cadian Capital Management GP, LLC | 0 | 2,920,681 | 0 | 2,920,681 | SCHEDULE 13G/A, 2026-08-14 |
| Eric Bannasch | 0 | 2,920,681 | 0 | 2,920,681 | SCHEDULE 13G/A, 2026-08-14 |
| Morgan Stanley | 0 | 2,190,498 | 0 | 2,246,650 | SCHEDULE 13G/A, 2026-08-13 |
| Morgan Stanley Capital Services LLC | 0 | 2,163,384 | 0 | 2,163,384 | SCHEDULE 13G/A, 2026-08-13 |
| Integrated Core Strategies (US) LLC | 0 | 1,556,718 | 0 | 1,556,718 | SCHEDULE 13G/A, 2026-07-29 |
| Millennium Management LLC | 0 | 1,724,726 | 0 | 1,724,726 | SCHEDULE 13G/A, 2026-07-29 |
| Millennium Group Management LLC | 0 | 1,724,726 | 0 | 1,724,726 | SCHEDULE 13G/A, 2026-07-29 |
| Israel A. Englander | 0 | 1,724,726 | 0 | 1,724,726 | SCHEDULE 13G/A, 2026-07-29 |
| The Vanguard Group | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-03-26 |
The latest filing identifies Cryoport, Inc. by CUSIP 229050307 and gives its principal executive office as 112 Westwood Place, Suite 350, Brentwood, TN 37027 (SCHEDULE 13G/A, 2026-08-14).
What the percentages are based on
As of June 30, 2026, each of the Reporting Persons may have been deemed to have beneficially owned approximately 5.8% of the shares of Common Stock of the Issuer outstanding, based on 50,648,491 shares of Common Stock outstanding as of June 30, 2026, as disclosed in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026.Cadian Capital Management, LP, SCHEDULE 13G/A, 2026-08-14
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-05 | Integrated Core Strategies (US) LLC | 4.4% | SCHEDULE 13G/A |
| 2025-08-13 | Brown Capital Management, LLC | 7.58% | SCHEDULE 13G/A |
| 2025-08-14 | Alger Associates, Inc. | 4.7% | SCHEDULE 13G/A |
| 2025-09-26 | Integrated Core Strategies (US) LLC | 5.1% | SCHEDULE 13G |
| 2025-11-12 | Brown Capital Management, LLC | 5.24% | SCHEDULE 13G/A |
| 2026-02-05 | Integrated Core Strategies (US) LLC | 6.5% | SCHEDULE 13G/A |
| 2026-02-17 | Brown Capital Management, LLC | 2.2% | SCHEDULE 13G/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-07-29 | Millennium Management LLC | 3.4% | SCHEDULE 13G/A |
| 2026-08-13 | Morgan Stanley | 4.5% | SCHEDULE 13G/A |
| 2026-08-14 | Cadian Capital Management, LP | 5.8% | SCHEDULE 13G/A |
Questions about who owns Cryoport, Inc.
Who owns Cryoport, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Cryoport, Inc.: Cadian Capital Management, LP (5.8%, Schedule 13G/A, filed 2026-08-14).
When did Cadian Capital Management, LP buy into Cryoport, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Cadian Capital Management, LP on this page is the Schedule 13G/A, filed 2026-08-14, reporting 5.8%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 11 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Cryoport, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.
